Review: Modelling the dialysate

Nephrology

Volumn 15, Issue 4, 2010, Pages 393-398

  Phipps, Lisa M ^a   Harris, David C H ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Dialysate; Disequilibrium; Haemodialysis; Hypotension; Profile; Sodium modelling

Indexed keywords

BICARBONATE; CALCIUM; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM; HEMODIALYSIS FLUID;

BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CONDUCTANCE; DIALYSATE; EXTRACELLULAR SPACE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAGNESIUM BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; SODIUM BLOOD LEVEL; ULTRAFILTRATION; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; EVIDENCE BASED MEDICINE; PERSONALIZED MEDICINE; RENAL REPLACEMENT THERAPY; TIME; TREATMENT OUTCOME;

BICARBONATES; CALCIUM; EVIDENCE-BASED MEDICINE; HEMODIALYSIS SOLUTIONS; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL; PHOSPHATES; POTASSIUM; RENAL DIALYSIS; SODIUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952894283     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01299.x     Document Type: Review

References (28)

1. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron. Physiol. 2003 93 : 94 101.
2. Mann H Stiller S, Gladziwa U, Konigs F. Kinetic modelling and continuous on-line blood volume measurement during dialysis. Nephrol. Dial. Transplant. 1990 5 (suppl S144 6.
3. Vankijk WHM, Wirtz JJM, Grave W et al. Vascular reactivity during combined ultrafiltration-haemodialysis: Influence of dialysate sodium. Nephrol. Dial. Transplant. 1996 6 : 323 328.
4. Parsons D, Yuill E, Llapitan M, Harris DCH. Sodium modelling and profiled ultrafiltration in conventional haemodialysis. Nephrology 1997 3 : 177 182.
5. Zhou YL, Liu HL, Duan XF, Yao Y, Sun Y, Liu Q. Impact of sodium and ultrafiltration profiling on hemodialysis related hypotension. Nephrol. Dial. Transplant. 2006 21 : 3231 3237.
6. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am. J. Kidney Dis. 1997 29 : 383 391.
7. Locatelli F, Andrulli S, Filippo Di et al. Effect of on-line conductivity plasma ultrafiltrate kinetic modelling on cardiovascular stability of hemodialysis patients. Kidney Int. 1998 53 : 1052 1060.
8. Donauer J, Kolbin D, Bek M, Krause A, Bohler J. Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects. Am. J. Kidney Dis. 2000 36 : 115 123.
9. Kovesdy C, Regidor D, Mehrota R et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2007 2 : 999 1007.
10. Cupisti A, Galetta F, Caprioli R et al. Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron 1999 82 : 122 126.
11. Redaelli B, Locatelli F, Limido D et al. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int. 1996 50 : 609 617.
12. Dolson G, Ellis K, Bernardo M, Prakash R, Adrogue H. Acute decreases in serum potassium augment blood pressure. Am. J. Kidney Dis. 1995 26 : 321 326.
13. Tentori F, Blayney M, Albert J et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 2008 52 : 519 530.
14. Toussaint N, Cooney P, Kerr PG. Review of dialysate calcium concentration in Hemodialysis. Hemodial. Int. 2006 10 : 326 337.
15. Argiles A, Kerr PG, Canaud B, Flavier JL, Mion C. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int. 1993 43 : 630 640.
16. Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol. Dial. Transplant. 2009 24 : 973 981.
17. Severi S, Grandi E, Pes C, Badiali F, Santoro A. Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: In vivo and in silico analysis. Nephrol. Dial. Transplant. 2008 23 : 1378 1386.
18. Kyriazis J, Glostos J, Bilirakis L et al. Dialysate calcium profiling during hemodialysis: Use and clinical implications. Kidney Int. 2002 61 : 276 287.
19. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: Implications in hypertension. J. Hypertens. 2000 18 : 1177 1191.
20. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am. J. Kidney Dis. 1999 34 : 43 8.
21. Goskel B, Torun D, Karaca S et al. Is low blood magnesium level associated with hemodialysis headache? Headache 2006 46 : 40 5.
22. Kelber J, Slatopolsky E, Delmez JA. Acute effects of different concentrations of dialysate magnesium during high efficiency dialysis. Am. J. Kidney Dis. 1994 24 : 453 460.
23. Elsharkawy M, Youssef A, Zayoon M. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial. Int. 2006 10 : S16 23.
24. Kyriazis J, Kalogeropoulou K, Bilirakis L et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004 66 : 1221 1231.
25. Palmer B. Individualizing the Dialysate in the Hemodialysis Patient. Semin. Dial. 2001 14 : 41 9.
26. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am. J. Kidney Dis. 1990 15 : 458 482.
27. Harris DCH, Yuill E, Chesher D. Correcting acidosis in hemodialysis: Effect on phosphate clearance and calcification Risk. J. Am. Soc. Nephrol. 1995 6 : 1607 1612.
28. Pierratos A, Ouwendyk M, Francouer R et al. Nocturnal hemodialysis: Three year experience. J. Am. Soc. Nephrol. 1998 9 : 859 868.